SAFETY AND EFFICACY OF DUAL THERAPY WITH DABRAFENIB AND TRAMETINIB IN AN INFANT WITH BRAF V600E MUTANT INOPERABLE LOW GRADE GLIOMA

被引：0
|
作者：
Green, Sage [1 ]
Walter, Andrew [1 ]
Piatt, Joseph [1 ]
Kaur, Gurcharanjeet [1 ]
机构：
[1] Nemours AI duPont Hosp Children, Wilmington, DE USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LGG-12
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [41] Sarcoid-like reaction in a child following prolonged therapeutic exposure to dabrafenib and trametinib for BRAF V600E mutated hypothalamic/chiasmatic glioma
    Wilhelmsson, Mari
    Chun, Foo Jen
    Yeung, Rae S. M.
    Krtizinger, Fiona
    McKeown, Tara
    Coblentz, Ailish
    Ertl-Wagner, Birgit
    Tabori, Uri
    Bartels, Ute
    Das, Anirban
    PEDIATRIC BLOOD & CANCER, 2024, 70 (11)
  • [42] Dabrafenib stimulates radioiodine uptake in BRAF V600E mutant advanced papillary thyroid cancer
    Rothenberg, Stephen M.
    McFadden, David G.
    Palmer, Edwin L.
    Daniels, Gilbert H.
    Wirth, Lori J.
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Pediatric BRAF (V600E)-Mutated Pancreatic Acinar Cell Carcinoma With Complete and Durable Response to Dabrafenib and Trametinib
    Cramer, Stuart
    Marcus, Matthew A.
    Ramkissoon, Shakti
    Szabo, Sara
    Pressey, Joseph G.
    JCO PRECISION ONCOLOGY, 2020, 4 : 801 - 805
  • [44] A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy
    Williams, Casey B.
    McMahon, Caitlin
    Ali, Siraj M.
    Abramovitz, Mark
    Williams, Kirstin A.
    Klein, Jessica
    McKean, Heidi
    Yelensky, Roman
    George, Thomas J., Jr.
    Elvin, Julia A.
    Soman, Salil
    Lipson, Doron
    Chmielecki, Juliann
    Morosini, Deborah
    Miller, Vincent A.
    Stephens, Philip J.
    Ross, Jeffrey S.
    Leyland-Jones, Brian
    ONCOTARGETS AND THERAPY, 2015, 8 : 3561 - 3564
  • [45] Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
    Long, G. V.
    Flaherty, K. T.
    Stroyakovskiy, D.
    Gogas, H.
    Levchenko, E.
    de Braud, F.
    Larkin, J.
    Garbe, C.
    Jouary, T.
    Hauschild, A.
    Chiarion-Sileni, V.
    Lebbe, C.
    Mandala, M.
    Millward, M.
    Arance, A.
    Bondarenko, I.
    Haanen, J. B. A. G.
    Hansson, J.
    Utikal, J.
    Ferraresi, V.
    Mohr, P.
    Probachai, V.
    Schadendorf, D.
    Nathan, P.
    Robert, C.
    Ribas, A.
    Davies, M. A.
    Lane, S. R.
    Legos, J. J.
    Mookerjee, B.
    Grob, J. -J.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1631 - 1639
  • [46] Response to the Combination of Osimertinib, Dabrafenib, and Trametinib in Leptomeningitis From EGFR-Mutant NSCLC With Acquired BRAF V600E Mutation: A Case Report
    Valet, Orion
    Swalduz, Aurelie
    Boussageon, Maxime
    Buisson, Adrien
    Avrillon, Virginie
    Mastroianni, Benedicte
    Perol, Maurice
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
  • [47] Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation
    Ueberroth, Benjamin E.
    Lieu, Christopher H.
    Lentz, Robert W.
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1448 - 1452
  • [48] Primary analysis of a phase II trial of dabrafenib plus trametinib (dab plus tram) in BRAF V600 mutant pediatric low-grade glioma (pLGG).
    Bouffet, Eric
    Hanford, Jordan
    Garre, Maria Luisa
    Hara, Junichi
    Plant-Fox, Ashley
    Aerts, Isabelle
    Locatelli, Franco
    Van der Lugt, Jasper
    Papusha, Ludmila
    Sahm, Felix
    Tabori, Uri
    Cohen, Kenneth J.
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Lali
    da Silva, Ana Bento Pereira
    Russo, Mark W.
    Hargrave, Darren R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17)
  • [49] BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma
    Jones, David T. W.
    Witt, Olaf
    Pfister, Stefan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (01) : 96 - +
  • [50] The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma
    Amaral, Teresa
    Nouri, Noura
    Garbe, Claus
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 705 - 715
12345